Upcoming Webinar
Please join us as Ned Pojskic, Vice President, Pharmacy Benefits Management presents the highlights of the fourth annual Green Shield Drug Trends report where we will provide valuable commentary, data and insights on the latest trends in pharmacy benefit management. This will include discussing trends related to Specialty drugs, Biologics and biosimilars as well as the impacts of new, more costly, chronic disease therapies.
New to this year’s report is the prevalence of mandatory generic substitution in drug plans, as well as a deep dive look at three therapeutic categories that are likely to have a significant impact on private drug plans. Date:
Thursday, May 16, 2024 Time: 1:00 - 2:00 PM ET Costs: Free - Members of any ISCEBS Chapter $30 - Non-Members Registration: Please click here to register. Add the event to your calendar and a Zoom meeting invitation will be provided just prior to the event. Questions: Email the chapter This program qualifies for 1 CEBS compliance credit. Visit www.cebs.org/compliance for more information. |
SPEAKER:
Ned Pojskic
Green Shield Ned Pojskic is Green Shield’s Vice President of Pharmacy Benefits Management. In this role, he is responsible for overseeing both the strategic and operational elements of the Green Shield Administration pharmacy benefits management function. On the strategic side, Ned leads a team of pharmacists and drug policy specialists responsible for setting Green Shield’s strategic direction with respect to pharmacy and drug benefits management, including product development and pharmaceutical industry partnerships. On the operational side, Ned’s scope of responsibility includes oversight of drug pricing, formulary management, specialty pharmacy, patient support programs, and drug prior authorization. With an industry background that includes a role as Director of Health Policy for the Ontario Pharmacists Association, Ned is a key member of the Green Shield Administration executive team. Ned holds Masters and PhD degrees from the Department of Pharmaceutical Sciences at the University of Toronto and is currently appointed as an adjunct lecturer within the Leslie Dan Faculty of Pharmacy. |